Premium
A PILOT TRIAL OF ADRIAMYCIN, PEMBROLIZUMAB, VINBLASTINE AND DACARBAZINE (APVD) FOR PATIENTS WITH UNTREATED CLASSICAL HODGKIN LYMPHOMA
Author(s) -
Lynch R.C.,
Smith S.D.,
Shadman M.,
Ujjani C.S.,
Kurtz D.M.,
Coye H.,
Till B.G.,
Warren E.H.,
Shustov A.R.,
Maloney D.G.,
Tseng Y.D.,
Gopal A.K.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.21_2632
Subject(s) - pembrolizumab , dacarbazine , medicine , brentuximab vedotin , abvd , vinblastine , oncology , nivolumab , chemotherapy regimen , regimen , bleomycin , chemotherapy , surgery , gastroenterology , lymphoma , immunotherapy , hodgkin lymphoma , vincristine , cyclophosphamide , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom